Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (822) Arrow Down
Filter Results: (822) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (822)
    • News  (150)
    • Research  (630)
    • Events  (1)
  • Faculty Publications  (363)

Show Results For

  • All HBS Web  (822)
    • News  (150)
    • Research  (630)
    • Events  (1)
  • Faculty Publications  (363)
← Page 18 of 822 Results →
  • 17 Jan 2018
  • Research & Ideas

If the CEO’s High Salary Isn't Justified to Employees, Firm Performance May Suffer

employee pay (such as worker performance and labor market characteristics), as well as the “unexplained pay ratio”—the portion of pay disparity not driven by economic factors. Rouen then studied how these measures of pay disparity... View Details
Keywords: by Dina Gerdeman
  • 05 Mar 2019
  • First Look

New Research and Ideas, March 5, 2019

towards those customers for whom the intervention will pay off, therefore increasing the value of customers while maximizing the return on the marketing efforts. Targeting effectively ultimately depends on the firm's ability to precisely... View Details
Keywords: Dina Gerdeman
  • Forthcoming
  • Article

Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation

By: Amitabh Chandra, Jennifer Kao, Kathleen L. Miller and Ariel Dora Stern
Regulators of new products confront a tradeoff between speeding a product to market and collecting additional product quality information. The FDA's Breakthrough Therapy Designation (BTD) provides an opportunity to understand if regulators can use new policy to... View Details
Keywords: Innovation and Invention; Governing Rules, Regulations, and Reforms; Government Administration; Research and Development; Pharmaceutical Industry
Citation
Find at Harvard
Register to Read
Related
Chandra, Amitabh, Jennifer Kao, Kathleen L. Miller, and Ariel Dora Stern. "Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation." Review of Economics and Statistics (forthcoming). (Pre-published online March 18, 2024.)
  • 01 Dec 2006
  • What Do You Think?

How Important Is Quality of Labor? And How Is It Achieved?

quality, not where he or she does it." These comments raise added questions: Just how do "standards" for quality in labor get set? Is this something suitable for governments? Or should the market be left to set the... View Details
Keywords: by by Jim Heskett
  • 2003
  • Article

Closing the Loop: Product Take-back Requirements and their Strategic Implications

By: Michael W. Toffel
In Asia, Europe, and North America, regulators are seeking to reduce waste disposal and develop recycling markets by requiring manufacturers to manage the end-of-life disposition of products they produce. Such policies attempt to "close the loop" for products ranging... View Details
Keywords: Wastes and Waste Processing; Energy Conservation; Product Development; Strategy; Policy; Governing Rules, Regulations, and Reforms; Manufacturing Industry; Asia; Europe; North and Central America
Citation
Read Now
Related
Toffel, Michael W. "Closing the Loop: Product Take-back Requirements and their Strategic Implications." Corporate Environmental Strategy 10, no. 9 (2003).
  • 18 Jun 2024
  • Research & Ideas

Industrial Decarbonization: Confronting the Hard Challenges of Cement

Cities like Cairo; Chongqing, China; Delhi; and Kinshasa, Congo are experiencing population explosions accompanied by unprecedented demand for homes, offices, factories, and infrastructure. In the United States, the Biden Administration’s policy-driven infrastructure... View Details
Keywords: by by Janelle Conaway; Green Technology; Energy; Industrial Products; Manufacturing
  • 2007
  • Book

Perspectives on Risk and Regulation: The FDA at 100

By: Arthur A. Daemmrich and Joanna Radin
Perspectives on Risk and Regulation: The FDA at 100 brings together the viewpoints of Food and Drug Administration officials and industry leaders on the future of regulating food, drugs, medical devices, and dietary supplements. In a period of rapid scientific... View Details
Keywords: Private Sector; Governing Rules, Regulations, and Reforms; Policy; Health Care and Treatment; Business and Government Relations; Risk and Uncertainty; Cooperation
Citation
Find at Harvard
Read Now
Related
Daemmrich, Arthur A., and Joanna Radin, eds. Perspectives on Risk and Regulation: The FDA at 100. Chemical Heritage Foundation, 2007. (Fulltext.)
  • 2012
  • Other Unpublished Work

Strategic responses to collective activism in the U.S. biomass sector

By: Shon R. Hiatt
Almost all companies face constraints and pressure from collective activists. Using tactics such as protests, boycotts, and lobbying, social movement organizations and collective actors can draw significant media attention to issues facing industries and organizations,... View Details
Keywords: Environmental Sustainability; Business and Community Relations; Social and Collaborative Networks; Governing Rules, Regulations, and Reforms; Identity; Forest Products Industry; United States
Citation
Related
Hiatt, Shon R. "Strategic responses to collective activism in the U.S. biomass sector." 2012.
  • 07 Sep 2011
  • First Look

First Look: Sept. 7

the mouse." Book: http://www.IMovedYourCheese.com Commentary: A View from the East: Trade, Investment, and Economic Reform Author:Regina M. Abrami Publication:In Cuban Economic and Social Development: Policy View Details
Keywords: Sean Silverthorne
  • 09 Nov 2010
  • First Look

First Look: November 9, 2010

experiments, and surveys of practice. The research has studied the interface among accounting information, capital markets, standard setters, and financial analysts and how managers make accounting choices. But as accounting scholars have focused on understanding how... View Details
Keywords: Sean Silverthorne
  • 08 Jul 2008
  • First Look

First Look: July 8, 2008

he says, will become longer, fatter, and more profitable. Elberse set out to investigate whether Anderson's long-tail theory is actually playing out in today's markets. She focused on the music and home-video industries—two markets that... View Details
Keywords: Martha Lagace
  • 08 Aug 2016
  • Working Paper Summaries

The Unintended Consequences of the Zero Lower Bound Policy

Keywords: by Marco Di Maggio and Marcin Kacperczyk; Banking
  • 02 Jul 2013
  • First Look

First Look: July 2

positive earnings surprises and positive analyst revisions in the months following passage of the bill, as well as significantly higher future sales and profitability. We show that the more complex the legislation, the more difficulty the View Details
Keywords: Anna Secino
  • 28 Jan 2008
  • Research & Ideas

Billions of Entrepreneurs in China and India

willing to give time, money, energy, and good will to their country of origin and is being pushed away. Fortunately, this situation has been changing in India in the last 4 to 5 years. In China, by and large, the diaspora has played a much bigger role. In 1978, China... View Details
Keywords: by Martha Lagace
  • January 2011 (Revised April 2011)
  • Case

CME Group

By: Forest L. Reinhardt and James Weber
The case describes CME Group, the world's largest commodities exchange, futures and options on futures contracts, history, regulation, and the strategic choices the company faced. CME Group was formed from the oldest and most well-known exchanges in the world. Traders... View Details
Keywords: Financial Crisis; Stocks; Goods and Commodities; Governing Rules, Regulations, and Reforms; Risk Management; Market Participation; Market Transactions; Financial Services Industry; United States
Citation
Educators
Purchase
Related
Reinhardt, Forest L., and James Weber. "CME Group." Harvard Business School Case 711-005, January 2011. (Revised April 2011.)
  • June 2009 (Revised July 2010)
  • Case

Microfin

By: Michael Chu and Enrique Kramer
The case presents the management dilemmas of a new institution in an undeveloped microfinance market in Latin America. Supported by a globally recognized industry player, it is the result of the efforts of two fledgling local entrepreneurs with a business model they... View Details
Keywords: Business Model; Developing Countries and Economies; Social Entrepreneurship; Microfinance; Governing Rules, Regulations, and Reforms; Industry Structures; Competitive Strategy; Financial Services Industry; Latin America
Citation
Find at Harvard
Related
Chu, Michael, and Enrique Kramer. "Microfin." Harvard Business School Case 309-126, June 2009. (Revised July 2010.)
  • 06 Dec 2011
  • First Look

First Look: Dec. 6

http://hbr.org/product/flying-without-a-net-turn-fear-of-change-into-fuel/an/10297-HBK-ENG The Real Consequences of Market Segmentation Authors:Sergey Chernenko and Adi Sunderam Publication:Review of Financial Studies (forthcoming)... View Details
Keywords: Sean Silverthorne
  • 24 Jul 2007
  • First Look

First Look: July 24, 2007

waste into by-product. In some cases, when the markets for the primary and by-products are "separable," it is optimal to convert only a portion of the waste into by-product and disposing of the rest. In other cases, when the... View Details
Keywords: Martha Lagace
  • October 2024
  • Article

Medicare Part D Protected-Class Policy Is Associated with Lower Drug Rebates

By: Pragya Kakani, Michael Anne Kyle, Amitabh Chandra and Luca Maini
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher spending. We estimated the association between protected-class status, US-level estimated... View Details
Keywords: Insurance; Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States
Citation
Find at Harvard
Purchase
Related
Kakani, Pragya, Michael Anne Kyle, Amitabh Chandra, and Luca Maini. "Medicare Part D Protected-Class Policy Is Associated with Lower Drug Rebates." Health Affairs 43, no. 10 (October 2024): 1420–1427.
  • 14 Aug 2018
  • First Look

First Look at New Research and Ideas, August 14, 2018

Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=54823 June 2018 Strategy Science Integrated Strategy: Residual Market and Exchange Imperfections as the Foundation of Sustainable Competitive Advantage By: Oberholzer-Gee,... View Details
Keywords: by Sean Silverthorne
  • ←
  • 18
  • 19
  • …
  • 41
  • 42
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.